Skip to main content

MoneyWorks4Me

Senores Pharmaceutic - Quaterly Results

30 Oct 2026 Evaluate
The sales surged to Rs. 356.50 millions, up 27.28% for the September 2026 quarter as against Rs. 280.10 millions during the corresponding quarter previous year.The Company has registered profit of Rs. 77.20  millions for the quarter ended September 2026, a growth of 20.06%  over Rs. 64.30 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 158.20 millions from 128.90 millions in the quarter ended September 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 356.50 280.10 27.28 626.40 441.40 41.91 1060.90 385.40 175.27
Other Income 147.60 186.80 -20.99 243.10 307.60 -20.97 663.50 219.90 201.73
PBIDT 158.20 128.90 22.73 230.40 201.20 14.51 476.70 147.10 224.07
Interest 22.20 15.80 40.51 44.40 33.40 32.93 69.80 65.20 7.06
PBDT 136.00 113.10 20.25 186.00 167.80 10.85 406.90 81.90 396.83
Depreciation 39.30 36.50 7.67 75.40 55.30 36.35 132.30 30.80 329.55
PBT 96.70 76.60 26.24 110.60 112.50 -1.69 274.60 51.10 437.38
TAX 19.50 12.30 58.54 23.10 21.20 8.96 72.10 14.20 407.75
Deferred Tax -0.60 2.10 -128.57 -0.10 7.10 -101.41 -12.40 -0.30 4033.33
PAT 77.20 64.30 20.06 87.50 91.30 -4.16 202.50 36.90 448.78
Equity 460.50 460.50 0.00 460.54 460.54 0.00 460.50 460.50 0.00
PBIDTM(%) 44.38 46.02 -3.57 36.78 45.58 -19.31 44.93 38.17 17.73
Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..